Skip to content
  • Home Home Home, current page.
  • Moments Moments Moments, current page.

Saved searches

  • Remove
  • In this conversation
    Verified accountProtected Tweets @
Suggested users
  • Verified accountProtected Tweets @
  • Verified accountProtected Tweets @
  • Language: English
    • Bahasa Indonesia
    • Bahasa Melayu
    • Català
    • Čeština
    • Dansk
    • Deutsch
    • English UK
    • Español
    • Filipino
    • Français
    • Hrvatski
    • Italiano
    • Magyar
    • Nederlands
    • Norsk
    • Polski
    • Português
    • Română
    • Slovenčina
    • Suomi
    • Svenska
    • Tiếng Việt
    • Türkçe
    • Ελληνικά
    • Български език
    • Русский
    • Српски
    • Українська мова
    • עִבְרִית
    • العربية
    • فارسی
    • मराठी
    • हिन्दी
    • বাংলা
    • ગુજરાતી
    • தமிழ்
    • ಕನ್ನಡ
    • ภาษาไทย
    • 한국어
    • 日本語
    • 简体中文
    • 繁體中文
  • Have an account? Log in
    Have an account?
    · Forgot password?

    New to Twitter?
    Sign up
barabasi's profile
Albert-László Barabási
Albert-László Barabási
Albert-László Barabási
@barabasi

Tweets

Albert-László Barabási

@barabasi

Network Scientist. Author. The Formula, Linked, Bursts. @Northeastern @Harvard @CEUhungary.

Boston, MA, Budapest, Hungary.
foundation.app/barabasilab
Joined July 2009

Tweets

  • © 2022 Twitter
  • About
  • Help Center
  • Terms
  • Privacy policy
  • Cookies
  • Ads info
Dismiss
Previous
Next

Go to a person's profile

Saved searches

  • Remove
  • In this conversation
    Verified accountProtected Tweets @
Suggested users
  • Verified accountProtected Tweets @
  • Verified accountProtected Tweets @

Promote this Tweet

Block

  • Tweet with a location

    You can add location information to your Tweets, such as your city or precise location, from the web and via third-party applications. You always have the option to delete your Tweet location history. Learn more

    Your lists

    Create a new list


    Under 100 characters, optional

    Privacy

    Copy link to Tweet

    Embed this Tweet

    Embed this Video

    Add this Tweet to your website by copying the code below. Learn more

    Add this video to your website by copying the code below. Learn more

    Hmm, there was a problem reaching the server.

    By embedding Twitter content in your website or app, you are agreeing to the Twitter Developer Agreement and Developer Policy.

    Preview

    Why you're seeing this ad

    Log in to Twitter

    · Forgot password?
    Don't have an account? Sign up »

    Sign up for Twitter

    Not on Twitter? Sign up, tune into the things you care about, and get updates as they happen.

    Sign up
    Have an account? Log in »

    Two-way (sending and receiving) short codes:

    Country Code For customers of
    United States 40404 (any)
    Canada 21212 (any)
    United Kingdom 86444 Vodafone, Orange, 3, O2
    Brazil 40404 Nextel, TIM
    Haiti 40404 Digicel, Voila
    Ireland 51210 Vodafone, O2
    India 53000 Bharti Airtel, Videocon, Reliance
    Indonesia 89887 AXIS, 3, Telkomsel, Indosat, XL Axiata
    Italy 4880804 Wind
    3424486444 Vodafone
    » See SMS short codes for other countries

    Confirmation

     

    Welcome home!

    This timeline is where you’ll spend most of your time, getting instant updates about what matters to you.

    Tweets not working for you?

    Hover over the profile pic and click the Following button to unfollow any account.

    Say a lot with a little

    When you see a Tweet you love, tap the heart — it lets the person who wrote it know you shared the love.

    Spread the word

    The fastest way to share someone else’s Tweet with your followers is with a Retweet. Tap the icon to send it instantly.

    Join the conversation

    Add your thoughts about any Tweet with a Reply. Find a topic you’re passionate about, and jump right in.

    Learn the latest

    Get instant insight into what people are talking about now.

    Get more of what you love

    Follow more accounts to get instant updates about topics you care about.

    Find what's happening

    See the latest conversations about any topic instantly.

    Never miss a Moment

    Catch up instantly on the best stories happening as they unfold.

    Albert-László Barabási‏ @barabasi 15 Apr 2020

    Really, BioArxiv, not posting COVID-19 papers before peer-review? The purpose of an ArXiv is to accelerate science. Never has the need for rapid access more imminent, than now, as doctors seek treatment to thousands of COVID patients! 1/3pic.twitter.com/ZJKNZLcwIU

    12:06 PM - 15 Apr 2020
    • 68 Retweets
    • 207 Likes
    • cengime Carmen Sergiou Luis M. Iglesias JP Scherzo n⛣el kuriakos Ray op'tLand, PhD The Virtual Metabolic Human Andreas Dräger Charlie Tapp
    bioRxiv SysBio and bioRxiv
    28 replies 68 retweets 207 likes
      1. New conversation
      2. Albert-László Barabási‏ @barabasi 15 Apr 2020

        How much redundant work is taking place because we are not aware what our colleagues have already solved or failed at? Yesterday there were 77 active trials for Hydroxychloroquine — and we know exactly why. Why lock out the science and let tweets drive clinical trials? 2/3

        2 replies 9 retweets 59 likes
        Show this thread
      3. Albert-László Barabási‏ @barabasi 15 Apr 2020

        I am with you -- patient safety first! But most scientist have login credentials to BioArxiv—stay true to your mission by creating a login-based COVID-19 list. 3/4

        2 replies 3 retweets 39 likes
        Show this thread
      4. End of conversation
      1. Rommie Amaro‏ @RommieAmaro 15 Apr 2020
        Replying to @barabasi @biorxiv_sysbio @biorxivpreprint

        My read is that they are requiring experimental verification, not peer review per se

        0 replies 1 retweet 19 likes
        Thanks. Twitter will use this to make your timeline better. Undo
        Undo
      1. J M‏ @TOLTECATLn 15 Apr 2020
        Replying to @barabasi @biorxiv_sysbio @biorxivpreprint

        How ironic! Commercial editorials going open access for COVID-19 papers and preprint servers asking for peer-review

        0 replies 0 retweets 2 likes
        Thanks. Twitter will use this to make your timeline better. Undo
        Undo
      1. Şeref Gül‏ @serefgulphd 15 Apr 2020
        Replying to @barabasi

        That’s what we learnt yesterday and shocked to be honest. It’s nonsense not to publish, not even “publish” but posting, in silico results without experiment!! According to this perspective they shouldn’t post in vitro results as well!

        0 replies 0 retweets 4 likes
        Thanks. Twitter will use this to make your timeline better. Undo
        Undo
      1. Şeref Gül‏ @serefgulphd 15 Apr 2020
        Replying to @barabasi @biorxiv_sysbio @biorxivpreprint

        It’s nonsense at all and against the sprit of preprints...

        0 replies 0 retweets 2 likes
        Thanks. Twitter will use this to make your timeline better. Undo
        Undo
      1. New conversation
      2. Ilia Teimouri‏ @IliaTeimouri 15 Apr 2020
        Replying to @barabasi @biorxiv_sysbio @biorxivpreprint

        Sad! Will you submit this on arXiv?

        1 reply 0 retweets 3 likes
      3. Albert-László Barabási‏ @barabasi 15 Apr 2020
        Replying to @IliaTeimouri @biorxiv_sysbio @biorxivpreprint

        yes

        0 replies 0 retweets 6 likes
      4. End of conversation
      1. Shahid Mukhtar‏ @SMukhtarlab 15 Apr 2020
        Replying to @barabasi @biorxiv_sysbio @biorxivpreprint

        I also got the same response. After removing the drug prediction component, I resubmitted and they took it.

        0 replies 0 retweets 4 likes
        Thanks. Twitter will use this to make your timeline better. Undo
        Undo
      1. New conversation
      2. Rajat Desikan‏ @rajatdesikan 15 Apr 2020
        Replying to @barabasi @biorxiv_sysbio @biorxivpreprint

        This is seriously disappointing! Are in silico papers banned on medrxiv too?

        1 reply 0 retweets 1 like
      3. Ash Jogalekar‏ @curiouswavefn 16 Apr 2020
        Replying to @rajatdesikan @barabasi and

        A few years ago J Med Chem made a decision that they wouldn’t publish any purely in silico papers with zero experimental validation. This was the right decision because they were getting flooded with a huge amount of cheap, purely computational riffraff.

        3 replies 2 retweets 24 likes
      4. Show replies

    Loading seems to be taking a while.

    Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

      Promoted Tweet

      false

      • © 2022 Twitter
      • About
      • Help Center
      • Terms
      • Privacy policy
      • Cookies
      • Ads info